MedTrace Logo

Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan

NCT00901875 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2012-11-30

No results posted yet for this study

Summary

To determine whether Suboxone can be effectively used to treat Taiwanese ethnic subjects with opiate dependence.

Conditions

  • Opiate Dependence

Interventions

DRUG

Buprenorphine + naloxone (Suboxone)

Sublingual tablets

DRUG

Buprenorphine + naloxone (Suboxone)

Sponsors & Collaborators

  • Taipei City Psychiatric Center, Taiwan

    collaborator OTHER

  • Indivior Inc.

    lead INDUSTRY

Principal Investigators

  • Shih-Ku Lin, MD · Department of Psychiatry, Taipei City Psychiatric Center, Taipei, Taiwan.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-11-30
Completion
2010-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00901875 on ClinicalTrials.gov